跳至主要内容
临床试验/TCTR20151122001
TCTR20151122001已完成未知

The Randomized Controlled Trial Study of the Incidence of Paclitaxel Hypersensitivity Reaction as First Line drug in Gynecologic Cancer Patients between 2 Steroid Premedication Type: Hydrocortisone & dexamethasone VS Dexamethasone alone

none0 个研究点目标入组 52 人开始时间: 2015年11月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 Years 至 80 Years(—)
性别
Female

入选标准

  • 1.Gynecologic cancer patient who had pathology report
  • 2.Need paclitaxel therapy
  • 3.Patient who had not been received paclitaxel
  • 4.Bone marrow, kidney,and liver were with in normal limit

排除标准

  • 1.allergy to hydrocortisone
  • 2.patient who had been received paclitaxel
  • 3.patient who had history of paclitaxel allergy

研究者

发起方
none

相似试验